SCHEMBL29670258

SCHEMBL29670258

C=C(C)C(=O)Oc1ccccc1C(=O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.64
KDM4E B2RXH2 4/20 0.54
HSD17B10 Q99714 4/20 0.54
TDP1 Q9NUW8 2/20 0.54
HPGD P15428 2/20 0.54
ALDH1A1 P00352 1/20 0.54
ESR1 P03372 1/20 0.54
ITGB3 P05106 1/20 0.54
ITGA2B P08514 1/20 0.54
HMGB1 P09429 1/20 0.54
TSHR P16473 1/20 0.54
GGT1 P19440 1/20 0.54
PTGS1 P23219 1/20 0.54
PTGS2 P35354 1/20 0.54
BLM P54132 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
MAPT P10636 3/20 0.53
MAPK1 P28482 2/20 0.53
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474811 1.00 ELANE (0.64) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL10662113 0.88 ELANE (0.57) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL820869 0.88 ELANE (0.57) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL14322808 0.87 ELANE (0.53) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL31315830 0.86 ELANE (0.61) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL5308300 0.86 KDM4E (0.72) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL29894584 0.85 ELANE (0.54) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL5506361 0.85 KDM4E (0.57) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL5506364 0.84 ELANE (0.57) ELANEKDM4EHSD17B10TDP1HPGD
SCHEMBL344654 0.84 KDM4E (0.70) ELANEKDM4EHSD17B10TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49528-E1 Bioactive coatings BIOINTERACTIONS LTD. (GB) 2023-05-16 US claimed
US-RE49522-E1 Bioactive coatings BIOINTERACTIONS LTD. (GB) 2023-05-09 US claimed
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2025-08-07 US disclosed
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen COLABS INT'L CORP. (US) 2023-10-26 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-11690793-B2 Composition containing a cellulose derived capsule with a sunscreen COLABS INT'L CORP. (US) 2023-07-04 US disclosed
US-20230113098-A1 Compositions Containing a Capsule with an Agent COLABS INT'L CORP. (US) 2023-04-13 US disclosed
US-11491088-B2 Compositions containing a capsule with a moisturizing agent CoLabs International Corporation (US) 2022-11-08 US disclosed
US-20220296483-A9 Composition Containing a Cellulose Derived Capsule With a Sunscreen CoLabs International Corporation (US) 2022-09-22 US disclosed
EP-3996670-A1 POLYURETHANE GELS Nanometics LLC (D.B.A. Phd Biosciences) (US) 2022-05-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent CUTA, LIPE, LIPA ELANE 189/4885KDM4E 2523/4885HSD17B10 2087/4885
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CUTA, ACMSD, TYR ELANE 268/4885KDM4E 2840/4885HSD17B10 1495/4885
US-20220296483-A9 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA ELANE 1317/4885KDM4E 478/4885HSD17B10 1950/4885
US-20230338252-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA ELANE 1317/4885KDM4E 478/4885HSD17B10 1950/4885
US-20230113098-A1 Compositions Containing a Capsule with an Agent LIPA, CUTA, FABP4 ELANE 164/4885KDM4E 3169/4885HSD17B10 2264/4885
US-11491088-B2 Compositions containing a capsule with a moisturizing agent CUTA, LIPA, PLIN5 ELANE 134/4885KDM4E 2683/4885HSD17B10 1970/4885
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents MSN, LIPE, CUTA ELANE 177/4885KDM4E 1505/4885HSD17B10 3508/4885
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents MSN, LIPE, CUTA ELANE 190/4885KDM4E 1510/4885HSD17B10 3630/4885
US-11690793-B2 Composition containing a cellulose derived capsule with a sunscreen MSH6, TYR, CUTA ELANE 1317/4885KDM4E 478/4885HSD17B10 1950/4885
US-20250248911-A1 Composition Containing a Cellulose Derived Capsule With a Sunscreen MSH6, TYR, CUTA ELANE 1317/4885KDM4E 478/4885HSD17B10 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.